Purpose: To find potentially diagnostic texture analysis (TA) features and to evaluate the diagnostic accuracy of two-dimensional (2D) magnetic resonance (MR) TA for differentiation between hepatocellular carcinoma (HCC) and benign hepatocellular tumors in the non-cirrhotic liver in an exploratory MR-study. Materials and methods: 108 non-cirrhotic patients (62 female; 41.5 AE 18.3 years) undergoing preoperative contrast-enhanced MRI were retrospectively included in this multi-center-study. TA including gray-level histogram, co-occurrence and run-length matrix features (total 19 features) was performed by two independent readers. Native fat-saturated-T1w and T2w as well as arterial and portal-venous post contrast-enhanced 2D-image-slices were assessed. Conventional reading was performed by two separate independent readers. Differences in TA features between HCC and benign lesions were investigated using independent sample t-tests. Logistic regression analysis was performed to obtain the optimal number/ combination of TA-features and diagnostic accuracy of TA analysis. Sensitivity and specificity of the better performing radiologist were compared to TA analysis. Results: The highest number of significantly differing TA-features (n ¼ 5) was found using the arterial-phase images including one gray-level histogram (skewness, p ¼ 0.018) and four run-length matrix features (all, p < 0.02). The optimal binary logistic regression model for TA-features of the arterial-phase images contained 13 parameters with an accuracy of 84.5% (sensitivity 84.1%, specificity 84.9%) and area-under-the-curve of 0.92 (95%-confidence-interval 0.85e0.98) for diagnosis of HCC. Conventional reading yielded a significantly lower sensitivity (63.6%, p ¼ 0.027) and no significant difference in specificity (94.6%, p ¼ 0.289) at best. Conclusion: 2D-TA of MR images is a feasible objective method that may help to distinguish HCC from benign hepatocellular tumors in the non-cirrhotic liver. Most promising results were found in TA features in the arterial phase images.
Introduction
Hepatocellular carcinoma (HCC) is the sixth most common cancer, the most common primary malignant liver tumor and in men the second leading cause of death due to cancer worldwide [1] . While HCC most frequently arises in a cirrhotic liver [2] , depending on the population, about 7.2e42.6% of HCCs also arise in noncirrhotic livers [3, 4, 5, 6] . Due to its high overall diagnostic accuracy for focal liver lesions, contrast-enhanced magnetic resonance (MR) imaging is currently the modality of choice for distinction of HCC and benign liver lesions in cirrhotic and non-cirrhotic livers [7, 8] . However, differentiation of HCC from focal nodular hyperplasia (FNH) and hepatic adenoma (HA) with atypical appearance is not always possible in the non-cirrhotic liver using state-of the art non-invasive or invasive techniques [9, 10] .
Although most HCCs can be detected by MRI there is limited diagnostic accuracy for atypical lesions in the non-cirrhotic liver, even with hepatocyte-specific contrast media as all hepatocellular tumors might lack or show hepatocyte-specific contrast media uptake [11, 12] .
Biopsy is performed in those cases to obtain histopathological diagnosis [13] although it is known that a liver biopsy is limited by a sampling error and high interreader variability, possibly leading to a false diagnosis due to tumor heterogeneity [14, 15] . Moreover, liver biopsy has the potential risk of tumor cell dissemination and intervention related complications like bleeding or infection. However, reliable biomarkers are needed to obtain an early diagnosis as the outcome for patients depends on the grade of HCC dedifferentiation [16, 17] .
Texture analysis (TA) is an objective region-of-interest (ROI) based image processing method, which allows to evaluate gray-level image features without the limitations of subjective judgment of a reader [18, 19] . Using TA, the structure of the analyzed image is assessed on several levels, e.g. its distribution of gray-levels in general or in neighboring voxels, and objective measures are derived. In recent years various studies have implemented TA of two-dimensional (2D) MR-images in different parts of the body such as brain [20] , prostate [21] , breast [22] and liver [23] . In these studies TA proofed to be a promising technique to distinguish or classify benign and malignant lesions [20, 21, 22, 23] .
The purpose of our study was to find potentially diagnostic TA features and to evaluate the diagnostic accuracy of 2D-MR-TA for differentiation between HCC and benign hepatocellular tumors in the non-cirrhotic liver in an MR-study.
Materials and methods
This study included data from an internationally registered multi-center study (ClinicalTrials.gov: NCT01234701). Institutional review board approval was obtained at the Ethics committee of the Canton Zurich and a waiver of written informed consent was obtained in each site. Data of this study population or parts of it were previously reported in different contexts [24, 25] .
Study population
A total of 108 non-cirrhotic patients (group: median age 45, range 18e85; females (n ¼ 62): 37.5, 18e85; males (n ¼ 46): 55.5, range 24e81) were retrospectively included in this multi-center study of five large international cancer care centers between January 2006 and June 2010. All patients underwent liver resection due to HCC, HA or FNH. Inclusion criteria were 1) age over 18 years, 2) no contraindications for MR-scanning, 3) contrast-enhanced MRI within two months prior to surgery 4) partial liver resection, 5) histopathological diagnosis of HCC, HA or FNH based on the total resected specimen, and 6) histopathological evidence of noncirrhotic liver-structure surrounding the lesion. Final diagnosis of the tumor was based on histopathology of the largest liver lesion of each patient.
patients with more than one liver lesion a radiologist, who was not involved in the image analysis, marked the resected lesion by slice position and location according to the hepatic segment numbering system of Couinaud.
Magnetic resonance imaging
Image acquisition was performed on 1.5T MRI-scanners (1xGenesis Signa, 1xSigna Horizon, GE Healthcare, Waukesha, WI; 1xSonata, 2xAvanto, Siemens Healthcare, Erlangen, Germany). For MR-imaging local optimized clinical protocols were used.
All MRI-protocols comprised of a spin-echo T2-weighted (T2w) sequence and a native fat-saturated gradient-echo T1-weighted (fs-T1w) sequence. Contrastenhanced fat-saturated gradient-echo T1-weighted sequences according to local optimized MRI-liver-protocols were obtained using an extracellular-fluid agent, a hepatobiliary-specific agent or extracellular-fluid agent in combination with a reticuloendothelial-specific agent. Gadoterate meglumine (Dotarem AG, Leverkusen, Germany) at doses as specified by the manufacturer. All protocols included acquisition of an arterial phase (10 seconds after contrast application) and a portal-venous phase (60 seconds after contrast application). In all patients, who received the hepatobiliary-specific agent a hepatospecific phase was acquired (10e30 minutes after contrast application). Relevant acquisition parameters can be found in Table 1 .
Image analysis
2D-TA was implemented in Matlab (MathWorks, Natick, MA) based on work of
Vallieres et al. [26] and Wei [27] . In short, gray-levels in the placed ROI were first normalized. Then the first-level TA-features based on the histogram of all graylevels in the ROI were computed (variance, skewness, kurtosis, entropy). Subsequently, the gray-level co-occurrence matrix (GLCM) was constructed based on the gray-level distribution within the ROI as introduced by Haralick et al [28] .
Briefly, this matrix contains the distribution of all possible pairs of gray-levels in neighboring pixels of a given image. Using the GLCM the second-level TA-features contrast, correlation, energy and homogeneity were derived. Finally, the gray-level run-length matrix (GLRLM) was constructed. This matrix basically depicts the distribution of the number of neighboring pixels with the same gray-levels on a straight line in a given image. From the GLRLM the second-level TA-features short-run emphasis (SRE), long-run emphasis (LRE), gray-level nonuniformity (GLN), Table 1 . Important MR sequence parameters. T1-weighted native and contrast-enhanced as well as T2-weighted images were used for texture analysis and for conventional reading. Additionally, in-and opposed-phase gradient-echo sequences were analyzed for conventional reading. In institution 1 after application of extracellular contrast medium a reticuloendothelial-specific contrast agent ferucarbotran (0.5 mmol Fe/ml) was additionally applied. None of the sequences with reticuloendothelial-specific contrast agent were used for texture analysis or conventional reading. images. Subsequently a ROI was defined in this slice including the whole lesion (cp. 
Statistical analysis
Interreader agreement for all TA-features and MR-sequences was assessed using the intra-class correlation coefficient (ICC), interreader agreement for conventional reading was measured using Cohen's kappa. An ICC of 0.75e1.00 indicated excellent, 0. between best performing binary logistic regression model and better performing radiologist were compared using McNemar's test. All statistical analyses were performed using SPSS (IBMÒ SPSSÒ Statistics 22; SPSSÒ Inc., Chicago IL). p < 0.05 was considered statistically significant.
Results
53 patients underwent MRI-examination with extracellular-fluid contrast agent, 43 patients with hepatobiliary-specific contrast agent and 12 patients with extracellular-fluid contrast agent in combination with a reticuloendothelial-specific contrast agent at a dose specified by the manufacturer (Table 1) . MRI phases with reticuloendothelial-specific contrast agent were not included into TA. 43 patients had more than one lesion, the presence of satellite lesion was evaluated in conventional reading but were not used for TA.
We Multiple TA-features showed statistically significant differences between the HCC group and the benign liver lesion group for almost all used MRI sequences. The majority of TA-features with statistically significant differences between HCCs and benign lesions were found when arterial phase images were assessed (n ¼ 5). These No statistically significant differences could be found when TAfeatures parameters in the T2w-images and in the hepatobiliary-phase images were assessed. Of note, although we found significant differences of some image features, there were also areas of overlap of these imaging features in HCCs and benign liver lesions. Box-plots of TA-features with significant differences between benign lesions and HCC for each patient are illustrated in Fig. 4 . Table 2 . The respective contingency tables are provided in Table 3 . Interreader agreement for conventional reading was fair with a kappa value of 0.33.
84 of 107 (78.8%) lesions were correctly diagnosed by MR Reader 1 and 67 of 107 lesions (62.6%) by MR Reader 2. These results, including diagnostic accuracy, sensitivity and specificity are summarized in Table 2 .
Sensitivity of the optimal binary logistic regression model derived from arterial phase images for the diagnosis of HCC versus benign liver lesions was statistically 
Discussion
In the present study we could show, that 2D-TA is a feasible method to distinguish malignant from benign hepatocellular tumors in the non-cirrhotic liver. Most promising results were obtained when assessing arterial phase images, where the most statistically differing TA-features (including gray-level histogram as well as run-length matrix features) between HCCs and benign hepatocellular tumors as well as the highest sensitivity, specificity and diagnostic accuracy for the correct classification of HCC were observed. In comparison to conventional reading the derived binary logistic regression model for TA-features of arterial phase images showed a statistically significant increased sensitivity while no statistical differences in specificity could be found.
Current American Association for the Study of Liver Disease (AASLD) guidelines (which were partly adopted by the European Association for the Study of the Liver (EASL)) state that HCC can be diagnosed by dynamic contrast-media (CM) enhanced MRI showing arterial CM uptake followed by washout of CM in the venous delayed phases for tumors larger than 1 cm in cirrhotic patients or patients with chronic hepatitis B [29, 30] . These features as well as the presence or absence of a pseudocapsule also play a major role in the liver imaging reporting and data system (LIRADS), which was introduced by the American College of Radiology (ACR)
to standardize reporting and diagnosis of HCC in patients at high risk [31] . However, all these features remain qualitative and therefore are prone to subjective misinterpretation. TA on the other hand provides objective quantitative measures and therefore e besides the definition of a ROI e lacks this subjective component. This behavior was confirmed in our study showing a substantially higher interreader agreement for TA than for conventional reading.
MRI specific imaging features of HCC should only be applied in patients with cirrhosis or patients with chronic hepatitis B who may not have developed cirrhosis yet [29] . Although cirrhosis is the strongest predisposing factor for HCC the annual incidence of HCC in the non-cirrhotic liver is as high as 0.4% [32] . Still there are no the surrounding liver parenchyma is seen. There was no significant change in signal intensity from the into the opposed-phase. Both MR readers misclassified this hepatocellular carcinoma as a focal nodular hyperplasia and hepatic adenoma, respectively, whereas texture analysis classified it correctly.
general guidelines for diagnosis of HCC in the non-cirrhotic patient. Therefore, LIR-ADS and EASL imaging criteria are commonly used for the classification of lesions in a non-cirrhotic liver as there are no systematic alternatives at the moment. Furthermore, Lin et.al [9] showed a lower sensitivity (78.9 % for CT and 65.0% for MRI) for the diagnosis of HCC in non-cirrhotic patients when compared to cirrhotic patients (85.3% for CT and 80.0% for MRI) and to our knowledge no study has assessed specificity in the non-cirrhotic patient yet.
While several TA-features showed statistically significant differences between benign liver lesions and HCC a significant overlap exists. This overlap limits the use of single TA-features for the correct classification of liver lesions even if the most appropriate MR sequence was used. Models using a combination of TAfeatures may provide a better approach to discriminate benign from malignant lesions. Indeed, using the optimal logistic regression model of TA-features we found a sensitivity of 84.9% and a specificity of 84.1% for the correct distinction of HCC from resected (and therefore most likely atypical) benign liver lesions, almost reaching the performance of MRI in patients with chronic liver disease (mainly cirrhosis, sensitivity 88%, specificity 94% [8] ) and outperforming the diagnostic accuracy of conventional reading in the present study.
During hepatocarcinogenesis from a dysplastic nodule over early HCC and welldifferentiated HCC to poor-differentiated HCC a typical shift from a portal vein dominated vascular supply to an arterial dominated vascular supply of the lesion is usually observed. When evaluating the assessed image sequences, we found the most promising results for the arterial phase images to distinguish HCC from benign liver lesions, while the accuracy for the portal-venous and hepatobiliary phase was worse. The above described transformation of the vascular supply during the stepwise development of HCC as well as the formation of leaky vessels in HCCs might be a possible explanation for this observation. The relative lack of differences of TAfeatures between HCC and HA as well as atypical FNH in the portal-venous and hepatobiliary phase images might be explained with the known similar behavior of HCC and HA in those phases due to a similar drainage pattern and commonly missing functional hepatocytes in these lesions. The poor performance for TA of the T2w images, however, might be explained with the heterogeneous data-set as both fatsaturated and non-fat-saturated T2w images were part of the data.
The following study limitations must be taken into account. First, MR-studies were acquired at different MR-scanners using locally optimized protocols and different contrast agents. This might have added to the observed variability and decreased measured sensitivity, specificity as well as diagnostic accuracy and might has also affected the diagnostic performance of TA. However, this setup reflects the current status of liver imaging at different centers and even in this setting significant differences could be observed. The potential impact of sequence parameters and image quality on TA-features was not part of this study and has to be evaluated in further studies. Second, additional sequences such as diffusion weighted imaging sequences might have improved the results of conventional reading and TA. Third, the obtained results are only valid for the used acquisition parameters and cannot be generalized for different MR-image acquisitions as these might have an influence on the derived TA-features. Fourth, a selection bias of the included lesions might be present as only resected liver lesions were included. Furthermore, due to the exploratory nature of the present study and the main goal to identify potentially diagnostic TA features, the derived binary logistic regression models were not rigorously corrected for multiple comparisons. Consecutively these results need to be validated in further future studies in a prospective manner.
In conclusion, we could show that 2D-texture-analysis of MR images is a feasible objective method that may help to distinguish malignant from benign hepatocellular tumors. The most promising results were found in TA features in the arterial phase images.
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